Joslin Diabetes Center study shows benefits of online discussion boards

November 29, 2005

Although having diabetes can sometimes feel isolating to individuals, participation in an Internet-based discussion group offers hope, inspiration and encouragement as well as bolsters people's perceived ability to cope with diabetes, according to a new study from Joslin Diabetes Center. The study, which appears in the November/December issue of The Diabetes Educator, examined the impact of Joslin's online Discussion Boards -- forums in which people with diabetes can find information and share thoughts and experiences on specific diabetes issues.

Established in 1998, the free service on Joslin's Web site (www.joslin.org) allows people from around the world to log on and post questions or comments about their diabetes-related concerns. The postings are moderated by a team of Joslin specialists, including physicians, nurse educators, dietitians, psychologists and exercise physiologists, all of whom can offer important perspectives about diabetes care.

"There's a strong therapeutic effect from posting on the board," says the study's lead investigator, John F. Zrebiec, M.S.W, C.D.E., a clinical social worker at Joslin and a lecturer at Harvard Medical School. "Diabetes can be a lonely disease," he says. While face-to-face support groups can help remedy isolation, for many people coming into a new group can be a "very anxiety-provoking experience," Zrebiec says. "Entering a group via the Internet can feel much less threatening and gives people an opportunity to talk about themselves in a much more anonymous way."

For the study, Zrebiec, who runs several of the discussion boards, tracked more than 330,000 visits to the discussion boards over a period of six years. In 1999 and again in 2004, computer-based customer satisfaction surveys were e-mailed directly to some of the board's registered users.

Nearly 75 percent of respondents to the study's 2004 survey rated participation in the discussion board as having a positive effect on coping with diabetes. As one woman commented, "I have found an oasis where I can be encouraged, inspired and educated by people who sincerely understand my struggles."

What's more, 71 percent of respondents stated participation helped them to feel more hopeful. One user, a representative of many, found the discussion board to be an online lifeline. "Here in Spain, I have no support," she commented. "I honestly don't know what I would do without the support I find here. It really has transformed my life and had a positive influence on the way I cope with diabetes."

Researchers report some 25 million Americans have been involved in traditional support groups for chronic diseases, including diabetes. But the findings from the Joslin study suggest that Internet-based groups are particularly valuable because they allow people from any part of the world to come together at any time. In addition, cyber-neighborhoods may offer people a less threatening venue for discussing particularly sensitive concerns about diabetes. As one user reflected, "I never thought I would be able to control the blood sugars because of the binge eating. I never felt able to share it with anyone. Now, I feel some hope.... It made the difference between feeling like a victim and feeling in control again."

The study also found a skyrocketing increase in use of Joslin's discussion boards over time. Since the board's launch in 1998, the number of people accessing the boards has risen by more than 1,100 percent to nearly 332,000 user sessions, and the average length of a user session increased by nearly 9 minutes to an average of 16 minutes.

In both the 1999 and 2004 surveys, most of the respondents were over 30 years old and female. This is consistent with studies that find that a high proportion of health information seekers are female, Zrebiec says. Postings about managing blood glucose readings, what to eat, the emotional ramifications of diabetes, and complications ranked high among topics of interest. Respondents reported getting 80 percent of their diabetes information on the Internet.

While it is too soon to tell how these trends ultimately will affect diabetes management, it is already clear that the Internet is changing how patients find healthcare information and emotional support. "The study results suggest that people with diabetes and their loved ones have a need to come together in cyber-neighborhoods to talk with others about similar problems, to learn coping strategies, and to maintain hope," Zrebiec says.
-end-
Funding for this study was provided by Joslin Diabetes Center. The citation for the article is The Diabetes Educator, Vol. 31, No. 6, November/December 2005, pp. 825-836.

About Joslin Diabetes Center
Joslin Diabetes Center, dedicated to conquering diabetes in all of its forms, is the global leader in diabetes research, care and education. Founded in 1898, Joslin is an independent nonprofit institution affiliated with Harvard Medical School. Joslin research is a team of more than 300 people at the forefront of discovery aimed at preventing and curing diabetes. Joslin Clinic, affiliated with Beth Israel Deaconess Medical Center in Boston, the nationwide network of Joslin Affiliated Programs, and the hundreds of Joslin educational programs offered each year for clinicians, researchers and patients, enable Joslin to develop, implement and share innovations that immeasurably improve the lives of people with diabetes. As a nonprofit, Joslin benefits from the generosity of donors in advancing its mission. For more information on Joslin, call 1-800-JOSLIN-1 or visit www.joslin.org.

Joslin Diabetes Center

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.